Show
Sort by
-
Environmental sustainability and antimicrobials : an underestimated problem with far-reaching consequences
-
- Journal Article
- A1
- open access
Safety and immunogenicity of a respiratory syncytial virus prefusion F (RSVPreF3) candidate vaccine in older adults : phase 1/2 randomized clinical trial
-
- Journal Article
- A1
- open access
Respiratory syncytial virus prefusion F protein vaccine in older adults
-
- Journal Article
- A1
- open access
Immune responses in healthy adults elicited by a bivalent norovirus vaccine candidate composed of GI.4 and GII.4 VLPs without adjuvant
-
- Journal Article
- A1
- open access
Double-blind, placebo-controlled, dose-escalating study evaluating the safety and immunogenicity of an epitope-specific chemically defined nanoparticle RSV vaccine
-
- Journal Article
- A1
- open access
Sanitary installations and wastewater plumbing as reservoir for the long-term circulation and transmission of carbapenemase producing Citrobacter freundii clones in a hospital setting
-
- Journal Article
- A1
- open access
Human immunity and susceptibility to influenza A(H3) viruses of avian, equine, and swine origin
-
Selective digestive decontamination-Pro
-
- Journal Article
- A1
- open access
Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate : a randomised, double-blind, placebo-controlled, phase 2a trial
-
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD) : a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial